insights_auto
Why is WXXWY down 2.58%?
Dive Deeperchevron_right
WXXWY:OTCMKTS
Wuxi Biologics Cayman ADR
$12.24
arrow_downward
-2.58%(-0.32) 1D
Oct 19, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for WXXWY...
Open
$12.19
High
$12.76
Low
$12.02
Mkt. cap
206.04B
Avg. vol.
64.29K
Volume
34.23K
52-wk high
$14.80
52-wk low
$7.30
Beta
0.01
Shares outstanding
2.06B
No. of employees
15K
Open
$12.19
High
$12.76
Low
$12.02
Mkt. cap
206.04B
Avg. vol.
64.29K
Volume
34.23K
52-wk high
$14.80
52-wk low
$7.30
Beta
0.01
Shares outstanding
2.06B
No. of employees
15K
News stories
From web sources and news partners
MarketWatch
·
58 minutes ago
Why smaller stocks face worse prospects than the S&P 500 in the coming years
TradingView
·
1 hour ago
Stock Market Today: Dow Jones Futures Rise, Nasdaq 100 Falls as Iran Threatens to Target Undersea Cables — SPCX, NFLX, STLD in Focus
Yahoo Finance
·
3 hours ago
Should You Wait Until After the Midterm Elections to Buy the S&P 500?
FXStreet
·
2 hours ago
Nasdaq and S&P 500 hold key support – But is another sell-off coming? [Video]
Profile
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
About Wuxi Biologics Cayman ADR